Billionaire Profile
Julian Baker
Global Rank
#1449

Image: Public domain | via Wikimedia Commons

Julian Baker

CEO, Baker Bros. Advisors LP
US
Real-Time Net Worth
$7.1B
As of December 2025
Age
59
Source
Biotech investing
Industry
finance-investments
Citizenship
US

Biography

Julian Baker is a prominent figure in the world of biotech investing, recognized for his significant contributions to the finance and investment industry. As of December 5, 2025, his estimated net worth is $7.1 billion. Baker's career began in the late 1980s with Credit Suisse First Boston Corporation's private equity arm, transitioning to a biotech-focused investment partnership with the Tisch family in 1994. In 2000, he co-founded Baker Bros. Advisors LP (BBA) with his brother Felix Baker, a firm specializing in long-term investments in biotechnology companies. Baker's achievements include managing billions in assets and serving on the boards of directors of several public companies, including Acadia Pharmaceuticals, Incyte Corporation, and Denali Therapeutics. His expertise and strategic vision have made him a key player in the biotech sector.

Wealth Over Time

In-Depth Profile

Early Life and Education

Julian Baker's journey began with a strong educational foundation. He holds an A.B. Magna Cum Laude from Harvard University.

Rise to Success

Baker's career in finance started at Credit Suisse First Boston Corporation's private equity arm from 1988 to 1993. He then moved into a biotech-focused investment partnership with the Tisch family in 1994. In 2000, he co-founded Baker Bros. Advisors LP (BBA) with his brother Felix Baker. BBA has been exceptionally successful, particularly in the healthcare sector, managing substantial assets and achieving significant returns on investments. The firm's investment strategy focuses on publicly traded life-sciences companies, primarily for major endowments and foundations.

Key Business Strategies

Baker's key business strategy involves long-term investment in biotechnology companies. Baker Bros. Advisors focuses on identifying promising companies and providing the financial backing for growth and development. The firm's success is attributed to its deep understanding of the biotech industry and a patient, research-driven investment approach.

Philanthropy

Julian Baker is actively involved in philanthropy through The J Baker Foundation Inc. The foundation supports several organizations, including the Centre for Hearing and Communication (CHC) and ALTSO, a non-profit providing orthopaedic care to children with limb disabilities. Baker also supports educational institutions like Harvard University and the Collegiate School in Manhattan.

Career Milestones

1988

Began Career

Employed by the private equity investment arm of Credit Suisse First Boston Corporation.

1994

Biotech Investing Partnership

Co-founded a biotechnology investing partnership with the Tisch Family.

2000

Co-founded Baker Bros. Advisors LP

Founded BBA with brother Felix Baker, a biotech-focused investment adviser.

2001

Lead Independent Director and Vice Chairman of Incyte Corporation

Started serving in this role.

2015

Director at Acadia Pharmaceuticals, Inc.

Began serving as a Director.

Philanthropy & Social Impact

Education and Health

The J Baker Foundation Inc

$56.3M

The foundation supports several organizations across multiple cities.